Jane Huang
President presso PRELUDE THERAPEUTICS INCORPORATED
Patrimonio netto: 243 246 $ in data 31/03/2024
Profilo
La dott.ssa Jane E. Huang, MD, è un Chief Medical Officer-Hematology presso BeiGene Ltd. La dottoressa Huang è stata precedentemente impiegata come vicepresidente e responsabile dello sviluppo clinico presso Acerta Pharma BV e come direttore medico di gruppo presso Genentech, Inc. Si è laureata alla Stanford University e ha conseguito il dottorato alla Washington University School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
04/04/2024 | 51 287 ( 0.09% ) | 243 100 $ | 31/03/2024 | |
BEIGENE LTD
0.00% | 17/04/2023 | 12 ( 0.00% ) | 146 $ | 31/03/2024 |
07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Jane Huang
Società | Posizione | Inizio |
---|---|---|
PROTARA THERAPEUTICS, INC. | Director/Board Member | 09/06/2021 |
PRELUDE THERAPEUTICS INCORPORATED | President | 04/04/2022 |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 05/04/2022 |
Precedenti posizioni note di Jane Huang
Società | Posizione | Fine |
---|---|---|
BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 03/04/2022 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Corporate Officer/Principal | 01/09/2016 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/03/2015 |
Formazione di Jane Huang
Stanford University | Undergraduate Degree |
Washington University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BEIGENE, LTD. | Health Technology |
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
PROTARA THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Jane Huang